Sign in

CIK 0001346830

  • Non-accelerated filer
  • Smaller reporting company

Tvardi Therapeutics, Inc.

Sign in to watch
Ticker
TVRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 713-489-8654
Business address
3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
Former names
Cara Therapeutics, Inc., Cara Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-06-26 Shiff Susan Ph.D. Director Grant or award · Stock Option (Right to Buy) +38,000 38,000
2020-06-12 Goncalves Joana Chief Medical Officer Sale −10,627 $15.20 $162K 35,373
2020-06-10 Goncalves Joana Chief Medical Officer Grant or award +30,000 46,000
2020-06-04 VOGELBAUM MARTIN Director Grant or award +14,400 20,400
2020-06-04 VOGELBAUM MARTIN Director Grant or award · Stock Option (Right to Buy) +21,600 21,600
2020-06-04 BAINS HARRISON M JR Director Grant or award +7,200 13,200
2020-06-04 BAINS HARRISON M JR Director Grant or award · Stock Option (Right to Buy) +10,800 10,800
2020-06-04 Ives Jeffrey L. Director Grant or award +7,200 13,200
2020-06-04 Ives Jeffrey L. Director Grant or award · Stock Option (Right to Buy) +10,800 10,800
2020-06-04 Posner Christopher Director Grant or award +7,200 13,200
2020-06-04 Posner Christopher Director Grant or award · Stock Option (Right to Buy) +10,800 10,800
2020-06-03 CHALMERS DEREK T President & CEO Sale −4,300 $16.01 $69K 966,421
2020-06-01 CHALMERS DEREK T President & CEO Sale −700 $16.00 $11K 970,721
2020-06-01 Ives Jeffrey L. Director Exercise or conversion +1,000 $9.94 $10K 7,000
2020-06-01 Ives Jeffrey L. Director Sale −1,000 $16.00 $16K 6,000
2020-06-01 Ives Jeffrey L. Director Exercise or conversion · Stock Option (Right to Buy) −1,000 0
2020-05-22 CHALMERS DEREK T President & CEO Sale −371 $16.00 $6K 971,421
2020-05-21 CHALMERS DEREK T President & CEO Sale −3,500 $16.00 $56K 971,792
2020-05-20 CHALMERS DEREK T President & CEO Sale −1,200 $16.00 $19K 975,292
2020-05-12 CHALMERS DEREK T President & CEO Sale −4,929 $16.00 $79K 976,492

Page 13 of 15 · 284 trades